Nesfatin-1: An affair of the heart

Endocrinology

Volumn 154, Issue 12, 2013, Pages 4443-4445

  Stengel, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PEPTIDE; GLUCOSE TRANSPORTER 4; HEART MUSCLE EXTRACT; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; NESFATIN 1; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; DNA BINDING PROTEIN; NERVE PROTEIN; NUCLEOBINDIN;

ACUTE HEART INFARCTION; ADIPOCYTE; ADIPOGENESIS; BLOOD; BODY FAT; CARDIOVASCULAR DISEASE; CELLULAR DISTRIBUTION; CEREBROSPINAL FLUID; CORONARY ARTERY DISEASE; ENZYME PHOSPHORYLATION; FLUID INTAKE; FOOD INTAKE; GLUCOSE HOMEOSTASIS; GONAD; HEART; HORMONE RELEASE; HUMAN; NONHUMAN; OBESITY; PANCREAS; PRIORITY JOURNAL; REPRODUCTION; SEX DIFFERENCE; SHORT SURVEY; STOMACH EMPTYING; STOMACH MUCOSA; WESTERN BLOTTING; ANIMAL; FEMALE; HEART MUSCLE CELL; MALE; METABOLISM;

ANIMALS; CALCIUM-BINDING PROTEINS; DNA-BINDING PROTEINS; FEMALE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; MALE; MYOCYTES, CARDIAC; NERVE TISSUE PROTEINS;

EID: 84888224452     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1966     Document Type: Short Survey

References (22)

1. Oh-I S, Shimizu H, Mori M, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006;443:709-712.
2. Stengel A, Goebel M, Wang L, et al. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology. 2009; 150:4911-4919.
3. Yosten GL, Samson WK. The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist. Am J Physiol Regul Integr Comp Physiol. 2010;298:R1642-R1647.
4. Gonzalez R, Kerbel B, Chun A, Unniappan S. Molecular, cellular and physiological evidences for the anorexigenic actions of nesfa-tin-1 in goldfish. PLoS One. 2010;5:e15201.
5. Yosten GL, Redlinger L, Samson WK. Evidence for a role of endogenous nesfatin-1 in the control of water drinking. J Neuroendocrinol. 2012;24:1078-1084.
6. Merali Z, Cayer C, Kent P, Anisman H. Nesfatin-1 increases anxi-ety- and fear-related behaviors in the rat. Psychopharmacology (Berl). 2008;201:115-123.
7. Yoshida N, Maejima Y, Sedbazar U, et al. Stressor-responsive central nesfatin-1 activates corticotropin-releasing hormone, noradrenaline and serotonin neurons and evokes hypothalamic-pituitary-adrenal axis. Aging (Albany NY). 2010;2:775-784.
8. Tanida M, Mori M. Nesfatin-1 stimulates renal sympathetic nerve activity in rats. Neuroreport. 2011;22:309-312.
9. Garcia-Galiano D, Navarro VM, Roa J, et al. The anorexigenic neuropeptide, nesfatin-1, is indispensable for normal puberty onset in the female rat. J Neurosci. 2010;30:7783-7792.
10. Stengel A, Goebel M, Yakubov I, Wang L, et al. Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology. 2009;150:232-238.
11. Gonzalez R, Tiwari A, Unniappan S. Pancreatic β cells colocalize insulin and pronesfatin immunoreactivity in rodents. Biochem Biophys Res Commun. 2009;381:643-648.
12. Ramanjaneya M, Chen J, Brown JE, et al. Identification of nesfa-tin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology. 2010;151:3169-3180.
13. Garcia-Galiano D, Pineda R, Ilhan T, et al. Cellular distribution, regulated expression, and functional role of the anorexigenic peptide, NUCB2/nesfatin-1, in the testis. Endocrinology. 2012;153:1959-1971.
14. Tsuchiya T, Shimizu H, Yamada M, et al. Fasting concentrations of Nesfatin-1 are negatively correlated with body mass index in nonobese males. Clin Endocrinol (Oxf). 2010;73:484-490.
15. Shimizu H, Oh-I S, Hashimoto K, et al. Peripheral administration of Nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology. 2009;150:662-671.
16. Nakata M, Manaka K, Yamamoto S, Mori M, Yada T. Nesfatin-1 enhances glucose-induced insulin secretion by promoting Ca(2+) influx through L-type channels in mouse islet β-cells. Endocr J. 2011;58:305-313.
17. Li Z, Gao L, Tang H, et al. Peripheral effects of nesfatin-1 on glucose homeostasis. PLoS One. 2013;8:e71513.
18. Gonzalez R, Reingold BK, Gao X, Gaidhu MP, Tsushima RG, Unniappan S. Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet β- and MIN6 cells. J Endocrinol. 2011;208:R9-R16.
19. Angelone T, Filice E, Pasqua T, et al. Nesfatin-1 as a novel cardiac peptide: identification, functional characterization, and protection against ischemia/reperfusion injury. Cell Mol Life Sci. 2013;70:495-509.
20. Feijoo-Bandin S, Rodriguez-Penas D, Garcia-Rua V, et al. Nesfa-tin-1 in human and murine cardiomyocytes: synthesis, secretion, and mobilization of Glut-4. Endocrinology. 2013;154:4757-4767.
21. Foo K, Brismar H, Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience. 2008;156:563-579.
22. Bloem B, Xu L, Morava E, et al. Sex-specific differences in the dynamics of cocaine- and amphetamine-regulated transcript and nes-fatin-1 expressions in the midbrain of depressed suicide victims vs. controls. Neuropharmacology. 2012;62:297-303.